Compare RGEN & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | MTH |
|---|---|---|
| Founded | 1981 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.7B |
| IPO Year | 1995 | 1997 |
| Metric | RGEN | MTH |
|---|---|---|
| Price | $144.40 | $75.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $167.67 | $77.63 |
| AVG Volume (30 Days) | 992.3K | ★ 999.1K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | 0.15 | ★ 0.82 |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.30 | N/A |
| Revenue Next Year | $14.52 | $9.81 |
| P/E Ratio | $959.67 | ★ $91.44 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $58.03 |
| 52 Week High | $175.77 | $85.38 |
| Indicator | RGEN | MTH |
|---|---|---|
| Relative Strength Index (RSI) | 62.11 | 50.28 |
| Support Level | $141.44 | $64.44 |
| Resistance Level | $149.05 | $80.57 |
| Average True Range (ATR) | 6.40 | 2.50 |
| MACD | 0.07 | -1.09 |
| Stochastic Oscillator | 80.80 | 13.74 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising twelve states: Arizona, California, Colorado, Utah, Tennessee, Texas, Alabama, Florida, Georgia, Mississippi, North Carolina, and South Carolina. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the Homebuilding segment.